Connect with us
European Gaming Congress 2024

Artificial Intelligence

Pharma R&D Outsourcing Global Market Report 2022: Increasing Collaboration and partnership among CROs and Stakeholders Drives Growth

Published

on

Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) — The “Pharma R&D Outsourcing Market – Global Outlook & Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering.

In a world of exponentially growing information, increasingly sophisticated technology, and an unstable economic environment, pharmaceutical corporations are increasingly outsourcing research efforts to academia and private contract research organizations (CROs).

The pharmaceutical R&D outsourcing market is expected to grow as pharmaceutical and biotechnology companies spend more on outsourced services. Outsourced R&D activities span basic research through late-stage development, including genetic engineering, target identification, target validation, assay creation, hit discovery and lead optimization (hit candidates-as-a-service), safety and efficacy assessments in animal studies, and human clinical trials.

MARKET DYNAMICS

Paradigm Shift Towards Virtual Clinical Trials

Advertisement
Stake.com
  • Virtual clinical trials or decentralized clinical trials can bring significant digital changes to clinical research methods and enhance the patient-centric ecosystem. These solutions include countless benefits such as technology, advanced applications, electronic devices, online social engagement platforms, artificial intelligence (AI), robotic process automation, and machine learning (ML).
  • Patient recruitment is the most prominent cause of clinical delay, followed by significant patient absenteeism. Approximately 30% of phase 3 study discontinuances are said to be due to difficulty recruiting patients. These delays can cost pharmaceutical companies/sponsors up to USD 8 million daily. However, a complete digital or cross model of patient enrolment is employed in decentralized clinical trials. This helps reach the recruitment target easily and rapidly, making the entire process easy, and engaging.

The Emergence of Artificial intelligence (AI) in Drug Discovery & Development

  • Artificial intelligence (AI) is used in numerous areas across the world. In healthcare, especially in the pharmaceutical industry, AI is making a notable change as it has varied uses in drug discovery & development, clinical trials, and pharmaceutical productivity. The life cycle of a new drug from a lab to a store is a chain of many complex events that take time and development. Such difficult circumstances can be minimized with the help of AI, and the target can be achieved in a short time.
  • Many pharmaceutical companies implement innovative technologies such as AI and machine learning to achieve high-quality results in a short amount of time. In pharmaceutical product development, AI can manage the drug designing, decision making, and therapy determination for patients with personalized medicines; the generated clinical data can be stored for future drug development.
  • Global key players from the pharma and biotech industry, such as Eli Lilly Amgen, Merck, LEO, AstraZeneca, Bayer, Novartis, J&J, and BASF, are now a part of machine learning for pharmaceutical discovery.

Increasing Collaboration and partnership among CROs and Stakeholders of the Pharmaceutical Ecosystem

  • New models are emerging, and the first innovation comes from the Clinical Research Organization (CRO). CROs establish early chemical / biological entry points for the disease, approach potential interested companies, and collaborate on integrated drug discovery projects that they have identified. Strategic partnerships have long been an essential feature of the pharmaceutical industry. Numerous in-licenses, out-licenses, joint research, and joint development agreements exist between biopharmaceutical companies and academic research institutes.
  • In recent years, several significant outsourcing partnerships were done, such as the UK-based AstraZeneca partnering with academic organizations, the Cambridge University, focusing on drug development. It partnered with the University of Texas MD Anderson Cancer Center in the United States to develop immunotherapy.

SEGMENTATION ANALYSIS

Segmentation by Product Type

  • Small Molecules
  • Biologics

Segmentation by Stage of Development

  • Clinical
  • Non-Clinical

Segmentation by Company Size

  • Small & Mid-Sized Companies
  • Large Companies

Segmentation by Therapy Area

  • Oncology
  • Cardiovascular Diseases
  • Infectious Diseases
  • Musculoskeletal Disorders
  • Central Nervous System Disorders
  • Gastrointestinal Disorders
  • Other Therapy Areas.

Segmentation by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Turkey
  • UAE

Key Vendors

  • Charles River Laboratories
  • ICON
  • IQVIA
  • Labcorp Drug Development
  • Medpace
  • Parexel International Corporation
  • Syneos Health
  • Thermo Fisher Scientific
  • Wuxi AppTec
  • Lonza
  • Boehringer Ingelheim
  • Samsung Biologics

Other Prominent Vendors

  • AbbVie
  • Advanced Clinical
  • BioAnalytix
  • Asymchem
  • Alcami
  • Bavarian Nordic
  • Catalent
  • Curia Global
  • ChemPartner
  • CMED
  • Criterium
  • Cromos Pharma
  • Evotec
  • Jubilant HollisterStier
  • KBI Biopharma
  • KCR S.A.
  • Kemwell Biopharma
  • Mesned Pharma Consult Center
  • Midas Pharma
  • Medelis
  • Merck KGaA
  • OCT Clinical
  • Pharmaceutics International
  • ProTrials Research
  • PROMETRIKA
  • QPS
  • Singota Solutions
  • Sofpromed
  • Sanofi
  • Taros chemicals
  • Veristat
  • Worldwide Clinical Trials
  • WuXi Biologics
  • Wacker Biotech B.V

Key Topics Covered:

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

Advertisement
Stake.com

5 Report Assumptions & Caveats

6 Market at a Glance

7 Introduction

8 Premium Insights

9 Market Opportunities & Trends

Advertisement
Stake.com

10 Market Growth Enablers

11 Market Restraints

12 Market Landscape

13 Stage of Development

14 Product

Advertisement
Stake.com

15 Company Size

16 Therapy Area

17 Geography

18 North America

19 Europe

Advertisement
Stake.com

20 APAC

21 Latin America

22 Middle East & Africa

23 Competitive Landscape

24 Key Company Profiles

Advertisement
Stake.com

25 Other Prominent Vendors

26 Report Summary

27 Quantitative Summary

28 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/lsf9z4

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Grant Cardone Lists $42M Miami Mansion on Blockchain Real Estate Platform Propy

Published

on

grant-cardone-lists-$42m-miami-mansion-on-blockchain-real-estate-platform-propy

American best-selling author, businessman, and investor chooses Propy’s onchain real estate platform to list Golden Beach, Florida, house.
MIAMI, July 2, 2024 /PRNewswire/ — Propy, a technology company revolutionizing real estate via blockchain and AI, today announced that high-profile American entrepreneur Grant Cardone has listed a Golden Beach, Florida, private property for sale on Propy’s blockchain-based real estate platform with an asking price of $42,000,000 accepting cryptocurrency. This marks the first venture into emerging technologies in proptech for Cardone, a serial founder, best-selling author, equity fund manager, and business and real estate investor. The home is listed on the Propy marketplace with the deed minted onchain.

Propy simplifies the home-purchasing experience and eliminates fraudulent transactions by using a decentralized title registry and an escrow settlement protocol for securely storing land records and facilitating transactions, as well as accepting or converting cryptocurrency if a buyer chooses this form of payment. Leveraging the immutability of the blockchain, Propy ensures that buyer and seller private information is secure throughout the transaction. Automating and bringing the entire process online and onchain enables closing on a property to be faster, easier, and more secure than the outdated, traditional real estate transaction model.
Commenting on the listing, Grant Cardone said, “We are all in on blockchain revolutionizing real estate. We are leveraging top-tier technology to make transactions seamless and unstoppable. This is the future of real estate, and we’re leading the charge!” 
The private address is minted on PropyKeys protocol – an onchain tokenized address market developed on the Base network (Coinbase Layer 2 on Ethereum). PropyKeys brings real estate onchain through NFT home addresses and aims to bring one million home addresses onchain by 2025. The Propy marketplace also grants prospective buyers the option to pay using Bitcoin or US dollars.
Natalia Karayaneva, Founder and CEO of Propy, said, “It is a privilege for us to be the platform of choice for high-end property sellers, enhancing our offering to our community of high net-worth individuals, investors, and crypto buyers. With Propy’s advanced blockchain rails, compliant crypto and dollar payments, and unwavering focus on privacy, our clients can confidently navigate the closing process. The inclusion of Cardone’s listing in BTC and USD on Propy, minted with our latest privacy deed feature, highlights our leadership in the intersection of real estate and crypto.”
Additional details on the Cardone property are available on Propy’s website. Interested parties should contact the listing agent for viewings and further details.
Natalia Karayaneva, Founder and CEO of Propy, is available for interview upon request.
About Propy:
Propy is a US-licensed title company and a pioneering platform leveraging blockchain and AI technology to facilitate seamless transactions of real-world assets (RWA), specifically focused on revolutionizing global real estate markets. As an industry leader, Propy specializes in providing secure and efficient solutions, ensuring an enhanced experience for buying and selling properties worldwide.
Website | Facebook | X 
Photo: https://mma.prnewswire.com/media/2452961/Grant_Cardone_mansion.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/grant-cardone-lists-42m-miami-mansion-on-blockchain-real-estate-platform-propy-302188274.html

Continue Reading

Artificial Intelligence

DataLend: Securities Lending Revenue Down 16% Year-Over-Year to $2.53 Billion in Q2 2024

Published

on

datalend:-securities-lending-revenue-down-16%-year-over-year-to-$2.53-billion-in-q2-2024

Global revenue declines year-over-year due to lagging equities performance in the U.S. and EMEA
NEW YORK, July 2, 2024 /PRNewswire/ — The global securities finance industry generated $2.53 billion in revenue for lenders in the second quarter of 2024, according to DataLend, the market data service of fintech EquiLend. The figure represents a 16% decrease from the $3.00 billion generated in Q2 2023.

Global broker-to-broker activity, where broker-dealers lend and borrow securities from each other, generated an additional $696 million in revenue during Q2, a 9% decrease year-over-year.
Regionally, equity revenue fell 33% in EMEA and 19% in North America compared to the same period last year. A 22% decline in fees in North America and a 23% dip in EMEA accounted for the majority of the decreased revenue. Equity revenue in APAC increased 8% thanks to a 13% increase in fees.
Global fixed income performance declined by 11% in Q2 year-over-year. While revenue from government securities was roughly flat, corporate debt revenue fell by 32%, a regression of a trend which saw corporate bonds running hot through much of 2022 and 2023.
In June 2024, the global securities finance industry generated $790 million in revenue for lenders. The figure represents a 11% decrease year-over-year from the $888 million generated in June 2023. Broker-to-broker activity totaled an additional $207 million in revenue in June, also an 11% decrease year-over-year.
The top five earners in June 2024 were Lucid Group (LCID US), Trump Media & Technology Group (DJT US), Canopy Growth Corporation NPV (CGC US & WEED CN), Beyond Meat Inc. (BYND US) and ImmunityBio Inc. (IBRX US). In total, the group generated $56 million in revenue in the month.
Bloomberg Terminal users can subscribe to EquiLend’s exclusive Orbisa securities lending data by entering terminal shortcut APPS ORBISA or clicking the following link: https://blinks.bloomberg.com/screens/apps%20orbisa.
About DataLend 
DataLend, the market data service within EquiLend’s Data & Analytics Solutions group, tracks daily market movements across more than 200,000 securities, covering $35 trillion in lendable assets and $2.6 trillion in on-loan assets for the securities finance market. www.datalend.com
About EquiLend
EquiLend is a global financial technology firm offering Trading, Post-Trade, Data & Analytics, RegTech and Platform Solutions for the securities finance industry. With offices in North America, EMEA and Asia-Pacific, EquiLend operates across various jurisdictions worldwide, adhering to the highest regulatory standards. The company is committed to excellence and innovation and is consistently recognized for its contributions to the industry. EquiLend is Great Place to Work Certified™ in the U.S., UK, Ireland and India and has been honored as the Best Post-Trade Service Provider Globally, Best Market Data Provider Globally and for its outstanding Diversity & Inclusion initiatives in the Securities Finance Times Industry Excellence Awards 2023. www.equilend.com
Logo – https://mma.prnewswire.com/media/1060364/EquiLend_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/datalend-securities-lending-revenue-down-16-year-over-year-to-2-53-billion-in-q2-2024–302188137.html

Continue Reading

Artificial Intelligence

Endpoint Security Market to Transcend USD 36.01 billion by 2031 Owing to Cutting-Edge Cybersecurity in Safeguarding Online Infrastructure| SkyQuest Technology

Published

on

endpoint-security-market-to-transcend-usd-36.01-billion-by-2031-owing-to-cutting-edge-cybersecurity-in-safeguarding-online-infrastructure|-skyquest-technology

WESTFORD, Mass., July 2, 2024 /PRNewswire/ — According to SkyQuest, the global Endpoint Security Market size was valued at USD 10.40 billion in 2022 and is poised to grow from USD 11.94 billion in 2023 to USD 36.01 billion by 2031, growing at a CAGR of 14.8% in the forecast period (2024-2031).

Organizations use advanced security solutions as their first line of defense in cybersecurity to protect their company network infrastructure. Market expansion is anticipated as Bring Your Own Device (BYOD) policies are implemented more frequently. For instance, the web threat intelligence detection XDR solution FortiXDR was introduced by Fortinet, Inc. BlackBerry Limited introduced the managed detection and response (MDR) service in a similar manner. Additionally, for endpoint security, Broadcom, Inc. has introduced Adaptive Protection. Solutions are heavily reliant on emerging technology, including cloud computing, artificial intelligence (AI), the Internet of Things (IoT), and others.
Download a detailed overview:
https://www.skyquestt.com/sample-request/endpoint-security-market
Endpoint Security Market Overview: 
Report Coverage 
Details 
Market Revenue in 2023 
$ 11.94 billion 
Estimated Value by 2031 
$ 36.01 billion 
Growth Rate 
Poised to grow at a CAGR of 14.8% 
Forecast Period 
2024–2031 
Forecast Units 
Value (USD Billion) 
Report Coverage 
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends 
Segments Covered 
Component, Enforcement Point, Enterprise Size, End-User and Deployment
Geographies Covered 
North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Report Highlights 
Updated financial information / product portfolio of players 
Key Market Opportunities 
Rising Number of Connected Devices
Key Market Drivers 
Rising trend of BYOD 
Segments covered in Endpoint Security Market are as follows:
ComponentSolutions (Endpoint Protection Platform (EPP) (Antivirus, Anti-Spyware/Anti-Malware, Firewall, Endpoint Device Control, Intrusion Prevention, Endpoint Application Control, Others), Endpoint Detection and Response (EDR)), Services (Professional Services (Training and Consulting, Integration and Implementation, Support and Maintenance), Managed Services)Enforcement PointWorkstations, Mobile Devices, Servers, Point of Sale Terminals, OthersEnterprise SizeLarge Enterprises, Small and Medium Enterprises (SMEs)End-UserGovernment & Public Sector, BFSI, Healthcare, IT & Telecom, Transportation, Education, Manufacturing, Retail & e-commerce, OthersDeploymentCloud, and On-PremiseRequest Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/endpoint-security-market
Large Enterprises Redefining Endpoint Security in Global Arena
The worldwide endpoint security market is shaped in large part by the size of the enterprise. The need for comprehensive and scalable solutions is generally driven by large organisations, whilst small and medium-sized enterprises (SMEs) prioritise cost-effective security measures that are suited to their specific needs. Market strategies and product development are influenced by this segmentation to effectively meet the diverse needs and budgets of organisations.
Large corporations have a great deal of influence in the global endpoint security market, owing to their sizable financial backing for all-encompassing cybersecurity solutions. By fitting by the artificial intelligence and machine learning technology as well as having the wide network infrastructure and following to regulation guidelines strictly, they hold an exclusive position to enhance ingenuity and expand market and at the same time set up security standards in the industry.
SMEs being small and financially limited create a big part of the world’s endpoint security demand driving demand for trustworthy, low-priced security solutions. Small and financially constrained firms need help protecting themselves from cyber threats as they tend to adopt new tech fast, yet they face higher risks of online attacks. This is due to SMEs are quick in adopting new technologies but are also at risk from online attacks.
View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/endpoint-security-market
Optimizing Performance through Strategic Deployment in Endpoint Security
Deployment in the worldwide endpoint security sector signifies the activities involving placing security systems into operation and orchestrating these solutions across various networks and gadgets. It is proverbial that deploying well means better protection from cyber-attacks, fewer weak points, more speed thereby preserving invaluable information for all organizations worldwide.
In the worldwide endpoint security industry, on-premises deployment gives users more control and customisation by installing security solutions directly on local servers and devices. This method is critical for companies with strict regulations on data security since it ensures that they adhere to legal requirements, directly control their sensitive information thereby upholding strong security and operational integrity.
In the worldwide endpoint security industry, cloud deployment uses remote servers to offer flexible, scalable security solutions. This approach is central in enabling organization to promptly respond to fresh dangers, reduce infrastructure budget and maintain reliable real time security on all endpoints as it is easy to incorporate, affordable and allows immediate updates.
Crucial Role of Enterprise Size and Advanced Deployment Strategies To turn Fruitful
Modern advanced security solutions are essential for safeguarding organisational network infrastructures in the quickly changing digital landscape of today. The increased spread of BYOD policies is driving demand for such cutting-edge solutions as Broadcom’s Adaptive Protection, BlackBerry’s MDR, and Fortinet’s FortiXDR. Advanced technology adoption, compliance, and scalability are key priorities for big enterprises, which use their large resource bases, while small and midsize businesses are pushing for good quality and affordable cybersecurity solutions. Efficient implementation, regardless of on-premises or cloud-based options, guarantees all-encompassing security and uninterrupted operations, providing defence against the continuously increasing risk of cyberattacks.
Related Reports:
Cyber Security Market
Network Security Market
Managed Security Services Market
Cloud Security Market
Application Security Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific. 
Contact:Mr. Jagraj SinghSkyQuest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
Logo : https://mma.prnewswire.com/media/2446095/SkyQuest_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/endpoint-security-market-to-transcend-usd-36-01-billion-by-2031-owing-to-cutting-edge-cybersecurity-in-safeguarding-online-infrastructure-skyquest-technology-302187917.html

Continue Reading

Trending